Chorioamnionitis is an inflammation in the fetal membranes or placenta. When chorioamnionitis de velops, fetal lungs are exposed to inflammatory cytokines and mediators via amniotic fluid. Because inflammation plays a pivotal role in the development of bronchopulmonary dysplasia (BPD), a chronic lung disease of prematurity, fetal lung inflammation induced by chorioamnionitis has been considered to be one of the major pathogenetic factors for BPD. Although there have been a number of studies that demon strated the relationship between chorioamnionitis and BPD, there are still controversies on this issue. The controversies on the relationship between chorioamnionitis and BPD arise from notunified definitions of chorioamnionitis and BPD, different study populations, and the proportion of contribution between inflammation and infectious microorganisms. The publication bias also contributes to the con troversies. Clinical trials targeting chorioamnionitis or microorganisms that cause chorioamnionitis will answer on the actual relationship between chorioamnionitis and BPD and provide a novel prophylactic strategy against BPD based on that relationship.
Introduction
Chorioamnionitis is a maternal inflammatory response that involves neutrophil infiltra tion in the fetal membranes or placenta with or without a fetal inflammatory response 1) . Chorio am nionitis has been known to be a major risk factor for preterm delivery and prematurity asso ciated morbidities 24) . Bronchopulmonary dysplasia (BPD) is one of the major morbidities of preterm infants and represents a chronic lung disease that develops exclusively inpreterm infants 5) . The association of chorioamnionitis and BPD has been reported in animal and human studies 69) . However, there are also not a few studies that reported con flicting results and the evi dence of publication bias, which lead to continuing controversies on the relationship between chorioamnionitis and BPD 9, 10) . In this review, the relationship between chorioamnionitis and BPD and the background for the controversy on this issue will be disussed. Because clinical chorioamnionitis can reflect other condi tions than true inflammation in the fetal membranes, placenta, and fetal tissue, only histologic chorioamnionitis will be discussed in this review.
The effect of chorioamnionitis on the development of BPD
Animal studies
There have been a number of animal studies which demonstrated an association of chorio amnionitis and BPD 11) . The sheep and rodent models of BPD had been established and the pathogenetic role of chorioamnionitis on the development of BPD has been searched in these animal models 1214) . The chorioamnio nitis or intraamnio tic inflam mation has been induced by intraamniotic lipopolysaccharide (LPS) injection or direct Ureaplasma urealyticum inoculation into amniotic sacs. The experimental chorioamnionitis consistently resulted in fetal lung maturational responses which can be reflected by a reduction of the alveolar septal thickness, restructuring of the double capillary system to a single capillary system, or increased surfactant pro duction 15) . However, these maturational responses were frequently followed by a disturbed lung development: fewer and larger distal airspaces resembling BPD of human preterm infants 13) .
In a newborn rat model of BPD devised by the author, experimental chorioamnio nitis induced by intraamniotic LPS not only directly inhibited alveolarization but also amplified the inhibitory effect of hypero xia on alveolarization 14) . However, in the same animal mo del, experimental chorioamnionitis protected the lungs against BPD triggered by postnatal systemic inflammation 15) , as shown in Fig. 1 . In a preterm fetal sheep model, intraamniotic Ureaplasma injection decreased elastic foci and increased smooth muscle around bronchioles and pulmonary arterioles which are distinctive patho logic findings seen in human BPD 1618) . Taken together, these animal studies supports that chorioamnionitis accelerates lung maturation but eventually disrupt normal lung development resulting in BPD.
Human studies
Despite not a few studies supporting the role of chorioamnionitis on the development of BPD, controversies continue on this issue 24, 19, 20) . The chorioamnionitis has been known to protect against respiratory distress syndrome (RDS). The beneficial effect of chorio amnionitis on the incidence of RDS has been shown under the exposure to antena tal corticosteroid 3, 4, 21) . However, this beneficial effect of chorio amnionitis on RDS may render the premature lungs more vulner able to various postnatal injuries 6, 7, 2224) . The chorio amnionitis increased the risk of BPD with a synergism with patent ductus arteriosus and mechanical ventilation 8, 24) . On the contrary, funisi tis, a type of chorioamnionitis primarily in volving umbilical cord, has been shown to protect against BPD in a study 10) . A recent metaanalysis by Hartling et al. 25) which included more than 15,000 infants demonstrated that chorioam nionitis is significantly associated with the development of BPD. In a retrospective cohort study by the author, while all types of chorioamnionitis decreased RDS, high grade amnionitis increased BPD 26) . However, in other cohort studies, chorioamnionitis was not associated with the de velopment of BPD 10, 27) . As in animal model of BPD, chorioamnionitis increased the development of BPD by adversely affecting various postnatal injuries including RDS, mechanical ventilation, and sepsis in the clinical observa tions 8, 23, 28) . This can also be expressed as cho rioamnionitis may make the preterm lungs to be more susceptible to postnatal injuries resulting in amplified inflammation and ultimately BPD 29) . However, there are a number of confounding factors that can be involved between chorioamnionitis and BPD. The diversity and uncertainty of diagnostic criteria of chorioamnionitis and BPD and inhomogeneity of the study populations also matter in in vestigating the relationship between chorioamnionitis and BPD. All these factors make the research for the role of chorioamnionitis in the development of BPD challenging.
Background for the controversies on the role of chorioamnionitis in the development of BPD
Definition of chorioamnionitis
The diversity and uncertainty of the definition of chorioamnio nitis may partly responsible for the controversies on the role of chorioamnionitis in the development of BPD. A recent systemic re view of 59 studies reported that the definition of chorioamnioni tis varied across the studies 25) . Different definitions of chorioamnionitis may confound the actual effect of chorioamnionitis on BPD. Fur thermore, because chorioamnionitis can vary in location and extent, it is too insufficient to identify the relation ship between chorioam nionitis and BPD, just to see if there is a chorioamnionitis or not. In this regard, the author investigated the relationship between chorio amnionitis on BPD using the defini tion of chorioamnionitis that reflects the location and extent of the inflammation 26) . In this study, the chorioamnionitis was divid ed into four categories according to the location of inflammation: any chorioamnionitis; amnionitis; funisitis; amnionitis plus funi si tis. Each category was further divided into high and low grades ac cording to the extent of inflammation. The results of the study revealed that high grade amnionitis in creases BPD. Because am nion lines the amniotic cavity, high grade amnionitis may indicate strong chemotactic stimuli within the amio tic cavity that will consequently results in fetal pul monary in flam mation and fetal lung damage. In this regard, the relationship between high grade amnionitis and BPD may be biologically plausi ble. Large scale cohort study that uses unified but subdivided criteria of chorio amnionitis will be needed to clarify the actual relation ship be tween chorioamnionitis and BPD.
Variations in the definition of BPD
It is important to have clear definition of BPD to compare out comes in clinical trials or quality improvement and to identify risk factors in epidemiological studies. Which definition of BPD is used will also affect the result of the investigation for the relationship between chorioamnionitis and BPD. The requirement of supplemen tal oxygen has been used as a surrogate for pulmonary dysfunction seen in BPD. The duration of oxygen dependency and the extent of supplemental oxygen needed to maintain ade quate arterial blood oxygen saturation have been used to define BPD and its severity. However, there has been a lack of uniformity in the definition of BPD among clinical trials and epide miological studies on BPD 30) . Moreover, the indications for oxygen supple mentation vary from center to center and from per son to person in a center. Among the definitions of BPD, the need for supple mental oxygen at 36 weeks postmenstrual age without a phy siologic test confirming the oxy gen dependency is the most fre quently used definition of BPD in clinical trials and epide miologic studies 31) . However the incidence of BPD diagnosed by this defini tion can be influenced by different strategies for oxygen supple mentation which will be different from center to center and from person to person in a center. Different arterial blood oxygen satu ration targets, different ventilatory strategies, and different medi cation practice will lead to different oxygen supple mentation strategies. In interpreting the results of the studies of the relation ship between chorioamnionitis and BPD, the definition of BPD used in the individual study should be taken into account.
Variations in the study population
The incidence of chorioamnionitis and BPD can vary according to the subject population studied. The lower the gestational age and birth weight, the higher the incidences of chorioamnionitis and BPD. Because the relationship between chorioamnionitis and BPD can also be influence by gestational age and birth weight, it is important to interpret the results of the studies on the relation ship between chorioamnionitis and BPD considering the characteristics of the study population. The effects of chorioam nionitis on the develop ment of BPD have been studied in differ ent popu lation groups 11) . Different study population may be one of the causes of controversy on the relationship between chorioamnio nitis and BPD.
Which contributes more: inflammation or infectious microorganisms?
The chorioamnionitis can be caused by a variety of stimuli. Most cases of chorioamnionitis are associated with intrauterine infections caused by genital mycoplasma like U. urealyticum 11) . A recent syste mic review reported that the exposure to Ureaplasma increased the incidence of BPD 32) . Ureaplasma has been believed to contribute to the development of BPD by dysregulating inflammatory responses in the immature lungs resulting in aberrant lung development and fibrosis 33) . Although intrauterine exposure to Ureaplasma is related to chorioamnionitis, the presence of Ureaplasma does not always overlap with chorioamnionitis 34) . A simple colonization of Ureapla sma in the fetal membranes or placenta can occur without inducing chorioamnionitis 35) . It is not yet known which of chorioamnionitis or Ureaplasma infection contributes more to the development of BPD. In studying the relation ship between chorioamnionitis and BPD, simply examining whe ther or not the chorioamnionitis is present can lead to incorrect conclusions. Both the type of microorganisms causing chorioamnionitis and the extent of chorioamnionitis by those microorganisms should be evaluated to clarify the actual relationship between chorioamnionitis and BPD.
Ureaplasma and BPD
Microorganisms are found in approximately 75% of the placenta with chorioamnionitis 36) . Most common microorganism isolated from the placenta or amniotic fluid of pregnant women with chorioamnionitis is Ureaplasma species 34) . The association of Urea plasma colonization with BPD has been demonstrated in human neonates by several metaanalyses that included more than 40 individual studies 32, 37, 38) . In animal studies including mice, sheep, and nonhuman primates, in utero Ureaplasma infection has been shown to induce a sustained dysregulated inflammatory response in the immature lungs that results in impaired alveolarization and excessive collagen and elastic deposition 39) . Disrupted alveolariza tion and airway and pulmonary vascular remodeling is a pathologic hallmark of BPD. The most definitive evidence for the role of Ure aplasma in the development of BPD will be obtained through the trial of antiUreaplasma agent in Ureaplasmainfected subjects. If the antiUreaplasma treatment can reduce the incidence of BPD in Ureaplasmainfected animals or human infants, the role of Urea plasma in the development of BPD will be proven. In the Rhesus monkey intrauterine Ureaplasma infec tion model, azithromycin delayed onset of labor, eradicated the infec tion, and prevented fe tal lung injury 40, 41) . However, prolong ed antenatal exposure to Ureaplasma infection resulted in per sistent chorioamnionitis and fetal lung injury in a sheep model despite a successful eradication of Ureaplasma by azithromycin or solithro mycin 42) . These results suggest that early detection of Ureaplasma infection will be essential for optimal timing of antiUreaplasma treatment to prevent fetal lung injury or BPD in the fetus or pre term infants infected with Ure aplasma. In human pre term infants, prophylactic azithromycin de creased the incidence of BPD. How ever, therapeutic macrolides did not decrease the incidence of BPD among Ureaplasmapositive pre term infants 43) . At the mom ent, there is not enough evidence that the eradication of Urea plasma results in a reduction of BPD. A phase IIB, placebocon trolled, randomized trial of the multidose azithromycin regimen in preterm infants is currently underway. The result of this clinical trial will provide us with the information on the effect of azithro mycin on the BPD and longterm neurodevelopmental out comes 39) .
Conclusions
The results of a number of animal experimental and human epidemiologic studies suggest that chorioamnionitis affects the development of BPD directly or indirectly. However, there are not a few limitations in the individual study. Notunified de finitions of the chorioamnionitis and BPD, differences in the study populations, and the proportion of contribution between inflamma tion and infectious microorganisms should be consi dered in interpreting the results of these studies. The results of the clinical trials of anti Ureaplasma or antiinflammatory treatment for pregnant women with chorioamnionitis or preterm infants who have been exposed chorioamnionitis will provide answer to the controversies on cau sal relationship between chorioamnionitis and BPD and a novel prophylactic strategy against BPD based on that relationship.
